PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Reactions Weekly10.1007/s40278-017-30986-z201716541253-253Nivolumabhttp://link.springer.com/content/pdf/10.1007/s40278-017-30986-z.pdf, http://link.springer.com/article/10.1007/s40278-017-30986-z/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-017-30986-z.pdf
The Korean Journal of Medicine10.3904/kjm.2018.93.2.2162018932216-219Diabetic Ketoacidosis Following Colonoscopy in Fulminant Type 1 Diabetes: A Case ReportDug-Hyun Choi, Bo-Yeon Kim, Chan-Hee Jung, Chul-Hee Kim, Sung-Koo Kang, Ji-Oh Mokhttp://ekjm.org/upload/kjm-2018-93-2-216.pdf, http://ekjm.org/journal/view.php?doi=10.3904/kjm.2018.93.2.216, http://ekjm.org/upload/kjm-2018-93-2-216.pdf
Reactions Weekly10.1007/s40278-018-43264-x201816931374-374Nivolumab/prednisonehttp://link.springer.com/content/pdf/10.1007/s40278-018-43264-x.pdf, http://link.springer.com/article/10.1007/s40278-018-43264-x/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-018-43264-x.pdf
Korean Diabetes Journal10.4093/kdj.2008.32.6.5342008326534The Classification of Diabetic Patients Presenting Diabetic Ketoacidosis: The Characteristics of Fulminant Type 1 DiabetesTae Sik Jung, Jong Ryeal Hahm, Jung Hwa Jung, Soon Il Chunghttp://synapse.koreamed.org/DOIx.php?id=10.4093/kdj.2008.32.6.534
Reactions Weekly10.1007/s40278-018-44295-4201816961107-107Clozapinehttp://link.springer.com/content/pdf/10.1007/s40278-018-44295-4.pdf, http://link.springer.com/article/10.1007/s40278-018-44295-4/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-018-44295-4.pdf
Reactions Weekly10.1007/s40278-017-37037-1201716721220-220Pembrolizumabhttp://link.springer.com/article/10.1007/s40278-017-37037-1/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-017-37037-1.pdf, http://link.springer.com/content/pdf/10.1007/s40278-017-37037-1.pdf
Reactions Weekly10.1007/s40278-016-18811-x201616071237-237Ipilimumab/pembrolizumabhttp://link.springer.com/content/pdf/10.1007/s40278-016-18811-x.pdf, http://link.springer.com/article/10.1007/s40278-016-18811-x/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-016-18811-x
Reactions Weekly10.1007/s40278-017-27116-5201716411202-202Olanzapinehttp://link.springer.com/content/pdf/10.1007/s40278-017-27116-5.pdf, http://link.springer.com/article/10.1007/s40278-017-27116-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-017-27116-5.pdf
Reactions Weekly10.1007/s40278-018-40327-8201816831390-390Ipilimumab/nivolumabhttp://link.springer.com/content/pdf/10.1007/s40278-018-40327-8.pdf, http://link.springer.com/article/10.1007/s40278-018-40327-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-018-40327-8.pdf
Diabetes Research and Clinical Practice10.1016/s0168-8227(08)70800-3200879S64P-26 Acute liver dysfunction due to therapy for diabetic ketoacidosis in a patient with fulminant Type 1 diabetesKaoru Isohttp://api.elsevier.com/content/article/PII:S0168822708708003?httpAccept=text/xml, http://api.elsevier.com/content/article/PII:S0168822708708003?httpAccept=text/plain